Navigation Links
Eppendorf Research Series 2100 Adjustable-volume Pipette, 0.1-2.5 l

ProductsEppendorf Research Series 2100 Adjustable-volume Pipette, 0.1-2.5 l
Company Eppendorf North America
Item Eppendorf Research Series 2100 Adjustable-volume Pipette, 0.1-2.5 l
Features 
Description Research Series 2100 Adjustable-volume Pipette, 0.1-2.5 l, single-channel with adjustable-volume setting
Info Eppendorf North America
Customer Service: (800) 645-3050
Web site: http://www.eppendorfna.com/home/

Related medicine products :

1. Eppendorf Thermomixer
2. Eppendorf Thermomixer R
3. Eppendorf ThermoStat Plus, without block
4. Eppendorf Refrigerated Multipurpose Centrifuge Model 5804R
5. Eppendorf Refrigerated Multipurpose Centrifuge Model 5810R
6. Eppendorf Heat Sealing Film
7. Eppendorf heat sealing film
8. Eppendorf PCR film, self adhesive
9. Eppendorf Heat Sealing Foil
10. Eppendorf PCR foil, self adhesive
11. Eppendorf Sealing Mat 96
Sterile, Coil Packed Suction Catheter Mini Tray with (2) Walleted SAFESKIN PURPLE NITRILE Latex-Free Exam Gloves
These economy suction kits include a Tri-Flo® suction catheter, a pop-up solution basin and one or two sturdy, precuffed vinyl exam gloves, without inner wallet. Infant and pediatric kits with 5/
Each tray kit includes a Tri-Flo® suction catheter, two powder-free vinyl gloves in an inner wallet and a rigid basin. Infant and pediatric kits (5/6, 8 and 10 Fr) feature depth markings. 100 kit
Each kit includes a Tri-Flo® suction catheter, 4-oz. sterile saline solution for flushing and lubrication, two latex-free nitrile gloves in an inner wallet and a rigid basin. Infant and pediatric
Medicine Products:
(Date:12/3/2008)...E, Ill., Dec. 3 Allied,National o... Lisle, Illinois,entered into an agreement to del...enhancing employee benefits with quality, savings ...erica,s flagship product, the Healthplace,Benefit... first -- and only --,comprehensive Surgery Benef...
(Date:12/3/2008)...re/ -- Teens are fascinated by their brains,the .... The American,Association for the Advancement of... and caregivers use that fascination to engage mid...in a discussion of why they shouldn,t drink,alcoh...d to convince their teens not to,drink alcohol, p...
(Date:12/3/2008)...dying the mechanics of blood clots, researchers at... discovered a new enzyme that not only affects the...ncer tumors expand and spread throughout the body....rnal Blood and the Journal of Thrombosis and Ha...rick McKee first discovered the enzyme called sFAP...
(Date:12/3/2008)...ewswire/ -- The four million Americans who,suffer...on for hope today with,the announcement of an unp...arkers for the illness and improve diagnosis and t... CFIDS Association of America, which is funding,t...tiative. , As part of this initiative, the ...
Breaking Medicine News(10 mins):Health News:Allied National Partners With Healthplace America to Provide Significant Healthcare Savings 2Health News:Allied National Partners With Healthplace America to Provide Significant Healthcare Savings 3Health News:When 'Just Say No' Isn't Enough: Try Science 2Health News:Researchers discover new enzyme in cancer growth 2Health News:New Research Will Benefit Four Million Americans Suffering from Chronic Fatigue Syndrome 2Health News:New Research Will Benefit Four Million Americans Suffering from Chronic Fatigue Syndrome 3Health News:New Research Will Benefit Four Million Americans Suffering from Chronic Fatigue Syndrome 4
...nts for weight loss has become a popular trend, bu...searchers say people should not assume herbal weig... //purchased without a prescription, they are not ...ugs. Researchers in Japan studied 12 patients who ...
...moving thousands of jars of pasta sauces because t...gasoline and shoe polish.// Sky News said consumer...ncluding Bertolli, as well as private-label sauces...ins Sainsbury's and Safeway. The alert follows th...
... thousands of children go to the emergency room wi...e bones before they’re put in a cast can be excruc...actures with only a fraction of the pain. There’s ... the more painful emergencies that we treat, say p...
...ity may increase the risk of certain types of cerv...National Institutes of Health, reveals obesity and...adenocarcinoma than with squamous cell carcinoma. ...nocarcinoma, 139 with squamous cell carcinoma, and...
Other Medicine News:
(Date:12/3/2008)...reatment alleviates long-term anemia and organ dam...ns , , MEMPHIS, Tenn., Dec. 3 /PRNewswire-...corrective gene into mouse blood cells, scientists...eviated sickle cell disease pathology. In their st... showed essentially no difference from normal mice...
(Date:12/3/2008)...N.Y., Dec. 3 The Leukemia & Ly...nce the beginning of a new clinical trial of ISF35...ia, San Diego (UCSD). , , LLS is collabo...ed the development and approval of a novel approac...actory and/or 17p deleted chronic lymphocytic leuk...
(Date:12/3/2008)...Pa., Dec. 3 Wyeth Pharma...nounced today that it has submitted a,marketing a...icines Agency,(EMEA) for approval to market its i...accine (PCV13) for infants and young children. Wy...f pneumococcal disease (PD) caused by the 13,sero...
(Date:12/3/2008)...Dec. 3 Isogen, a contract developm...lling, announced it has retained a,strategic fina... the global,biopharma demand for Isogen,s service...essful first round series of capital,investment a...in Q1 2009 to,deliver on the previously unmet pro...
Breaking Medicine Technology:Gene Therapy Corrects Sickle Cell Disease in Laboratory Study 2Gene Therapy Corrects Sickle Cell Disease in Laboratory Study 3The Leukemia & Lymphoma Society and Memgen Announce New Chronic Lymphocytic Leukemia Clinical Trial 2The Leukemia & Lymphoma Society and Memgen Announce New Chronic Lymphocytic Leukemia Clinical Trial 3Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 2Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 3Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 4Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 5Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 2Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 3National Stem Cell Holding Inc Discovers Non Embryonic Biomaterials that Promote Tissue Repair 31 1National Stem Cell Holding Inc Discovers Non Embryonic Biomaterials that Promote Tissue Repair 31 2National Stem Cell Holding Inc Discovers Non Embryonic Biomaterials that Promote Tissue Repair 31 3Multiple Myeloma Research Consortium 28MMRC 29 Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor 27 1Multiple Myeloma Research Consortium 28MMRC 29 Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor 27 2Multiple Myeloma Research Consortium 28MMRC 29 Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor 27 3Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T Cell Lymphoma 23 1Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T Cell Lymphoma 23 2Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T Cell Lymphoma 23 3Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T Cell Lymphoma 23 4Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine 19 1Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine 19 2Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine 19 3
...SE: ALGETA), the,Norwegian cancer therapeutics com...nd, of the Norwegian Radium Hospital, Oslo and,fou...on entitled,"Radium-223 in the treatment of metas...esults from a randomized,placebo-controlled, phas...ncology,s annual meeting (1-5 June 2007, Chicago,...
...ll/ -- Vical,Incorporated today announced that a m...axfectin(TM) adjuvant elicited protective,levels o...old),nonhuman primates confirmed by complete prote... vaccination, and sterilizing,immunity as evidence...e virus after challenge. In a separate study, the ...
Other Medicine Technology:Algeta to Present Phase II Clinical Study Data for Alpharadin in,Prostate Cancer at ASCO 2Vaxfectin-formulated Measles DNA Vaccine Elicits Long-term,Protection and Sterilizing Immunity in Nonhuman Primates 2Vaxfectin-formulated Measles DNA Vaccine Elicits Long-term,Protection and Sterilizing Immunity in Nonhuman Primates 3Vaxfectin-formulated Measles DNA Vaccine Elicits Long-term,Protection and Sterilizing Immunity in Nonhuman Primates 4